Urodat 0.5mg Capsule is used in the treatment of benign prostatic hyperplasia. It shrinks the size of the enlarged prostate gland to relieve symptoms like pain and difficulty in passing urine.

It should be taken by mouth with or without food. This medicine is given for long time as takes few months to show its effects. Thus, it is important to take it as advised by doctor and complete the full course of treatment.

It is usually well tolerated. However, it may produce some mild sexual side effects such as low sexual drive. Remember you should not donate blood for 6 months after taking the last dose of this medicine.

Uses of Urodat Capsule

Side effects of Urodat Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Urodat

Decreased libido
Ejaculation disorder
Breast enlargement in male
Breast tenderness in male
Impotence
Decreased sperm count

How to use Urodat Capsule

Take this medicine in the dose and duration as advised by your doctor. Urodat 0.5mg Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Urodat Capsule works

Urodat 0.5mg Capsule is a 5-alpha reductase inhibitors. It blocks an enzyme which is necessary to change testosterone to another hormone that causes the prostate to grow. As a result, it helps to shrink the prostate and relieve the symptoms like difficulty in passing urine.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Urodat 0.5mg Capsule. Please consult your doctor.

Pregnancy

UNSAFE

Urodat 0.5mg Capsule is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding

UNSAFE

Urodat 0.5mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Urodat 0.5mg Capsule is not indicated for use in women.

Driving

SAFE

Urodat 0.5mg Capsule does not usually affect your ability to drive.

Kidney

SAFE IF PRESCRIBED

Urodat 0.5mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Urodat 0.5mg Capsule may not be needed in these patients. Please consult your doctor.

Liver

CAUTION

Urodat 0.5mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Urodat 0.5mg Capsule may be needed. Please consult your doctor.
Use of Urodat 0.5mg Capsule is not recommended in patients with severe liver disease.

What if you forget to take Urodat Capsule?

If you miss a dose of Urodat 0.5mg Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.\n

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Urodat 0.5mg Capsule

₹11.1/Capsule

Dutas Capsule

Dr Reddy's Laboratories Ltd

₹46.1/capsule

315% costlier

Dutafast 0.5mg Capsule

Aethicz Biolife

₹9/capsule

19% cheaper

Duprost Capsule

Cipla Ltd

₹31.9/capsule

187% costlier

Dutride 0.5mg Capsule

Swati Spentose Pvt Ltd

₹13.1/capsule

18% costlier

Dupecia 0.5mg Capsule

Cipla Ltd

₹13/capsule

17% costlier

View all substitutes

Quick tips

Your doctor has prescribed Urodat 0.5mg Capsule to shrink the enlarged prostate and reduce the risk of urinary retention.
It may take 3 to 6 months to see the full beneficial effect of Urodat 0.5mg Capsule. Hence, continue taking the medicine as advised by your doctor.
Urodat 0.5mg Capsule is usually well tolerated. However, it may produce some mild sexual side effects such as low sexual drive.
Do not donate blood for 6 months after taking the last dose of Urodat 0.5mg Capsule.

Fact Box

Chemical Class

Androgen Derivative

Habit Forming

Therapeutic Class

UROLOGY

Action Class

5-Alpha Reductase Inhibitors (5ARIs)

Interaction with drugs

Taking Urodat with any of the following medicines can modify the effect of either of them and cause some undesirable side effects

Aprepitant (Injection Route) Moderate

Aprepitant may raise blood levels of Dutasteride. watch out for symptoms such as reduced sexual drive, dizziness, blisters or mood changes and consult your doctor if you experienc... More

Atazanavir (Oral Route) Moderate

Atazanavir may raise blood levels of Dutasteride. watch out for symptoms such as reduced sexual drive, dizziness, blisters or mood changes and consult your doctor if you experienc... More

Cholestyramine (Oral Route) Moderate

Cholestyramine may reduce the efficacy of Dutasteride. To take Dutasteride, ensure a gap of 1 hour before and 6 hours after taking Cholestyramine.

Conivaptan (Injection Route) Moderate

Conivaptan may raise blood levels of Dutasteride. watch out for symptoms such as reduced sexual drive, dizziness, blisters or mood changes and consult your doctor if you experienc... More

Aprepitant (Oral Route) Moderate

Aprepitant may raise blood levels of Dutasteride. watch out for symptoms such as reduced sexual drive, dizziness, blisters or mood changes and consult your doctor if you experienc... More

View all drug interactions

Patient concerns

What is hyperplasia nd wht a treatment

Dr. Banashree Majumdar

Dermatology

Mr. PATIENT is not a medical condition, it's just a histological term mentioned in pathology reports

Sir please advice PSA very rise

Dr. Vijay Sharnangat

Medical Oncology and Hematology

It's benign enlargement of prostate

At this stage of menopause, I am taking Tab menopace and triple a cal tab. For my hair loss I would like to take tab Kera glow eva which is also multi vitamin tab. Should I continue with both tab or stop taking menopace tab and calcium tab. Thanks

Dr. Sunil Sekhri

Diabetology

No need to take the medicine for Hair loss. eat a well balanced diet and hair loss of upto 100 hairs per day is considered normal

Related ayurvedic ingredients

Pumpkin

LAVENDER

Top Physicians

4.9 ★

4.5 ★

4.3 ★

4.2 ★

4.3 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 723.
Dutasteride. Research Triangle Park, North Carolina: GlaxoSmithKline; 2001 [revised Jun. 2008]. [Accessed 04 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
Dutasteride [Product Monograph]. Mississauga, Ontario: GlaxoSmithKline Inc.; 2013. [Accessed 20 June 2023]. (online) Available from:

Marketer details

Name: Oriental Pharma

Address: A-294, Okhla Phase-1, New Delhi-110 020

Country of origin: India

NOT FOR SALE

We do not facilitate sale of this product at present

We provide you with authentic, trustworthy and relevant information

Have issue with the content?